Compare NABL & AZTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NABL | AZTA |
|---|---|---|
| Founded | 2000 | 1978 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Industrial Machinery/Components |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.6B |
| IPO Year | N/A | 1995 |
| Metric | NABL | AZTA |
|---|---|---|
| Price | $6.45 | $39.12 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | $9.45 | ★ $43.20 |
| AVG Volume (30 Days) | ★ 968.4K | 508.0K |
| Earning Date | 03-02-2026 | 02-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $497,665,000.00 | ★ $593,821,000.00 |
| Revenue This Year | $11.18 | $6.18 |
| Revenue Next Year | $8.73 | $5.24 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 8.65 | 3.55 |
| 52 Week Low | $6.07 | $23.91 |
| 52 Week High | $10.41 | $55.64 |
| Indicator | NABL | AZTA |
|---|---|---|
| Relative Strength Index (RSI) | 35.61 | 58.00 |
| Support Level | $6.19 | $38.86 |
| Resistance Level | $6.82 | $41.73 |
| Average True Range (ATR) | 0.25 | 1.25 |
| MACD | -0.04 | -0.02 |
| Stochastic Oscillator | 20.00 | 46.00 |
N-able Inc is a provider of cloud-based software solutions for managed service providers (MSPs), enabling them to support digital transformation and growth for small and medium-sized enterprises. With a flexible technology platform and powerful integrations, N-able makes it easy for MSPs to monitor, manage, and protect their end-customer systems, data, and networks. The company's growing portfolio of management, security, automation, and data protection solutions is built for IT services management professionals. Geographically, the majority of revenue is from the United States. The company also has a presence in the United Kingdom and all other International regions.
Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.